223 related articles for article (PubMed ID: 30217376)
1. Lifetime Pattern of Atrial Fibrillation and the Risks of Stroke and Death in a Population-based Cohort of Men (from The Manitoba Follow-Up Study).
McIntyre WF; John PDS; Torabi M; Tate RB
Am J Cardiol; 2018 Nov; 122(10):1688-1693. PubMed ID: 30217376
[TBL] [Abstract][Full Text] [Related]
2. Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation.
Padfield GJ; Steinberg C; Swampillai J; Qian H; Connolly SJ; Dorian P; Green MS; Humphries KH; Klein GJ; Sheldon R; Talajic M; Kerr CR
Heart Rhythm; 2017 Jun; 14(6):801-807. PubMed ID: 28232263
[TBL] [Abstract][Full Text] [Related]
3. Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction.
O'Neal WT; Sandesara P; Hammadah M; Venkatesh S; Samman-Tahhan A; Kelli HM; Soliman EZ
Am J Cardiol; 2017 Jun; 119(11):1785-1790. PubMed ID: 28395886
[TBL] [Abstract][Full Text] [Related]
4. Effect of race on outcomes (stroke and death) in patients >65 years with atrial fibrillation.
Kabra R; Cram P; Girotra S; Vaughan Sarrazin M
Am J Cardiol; 2015 Jul; 116(2):230-5. PubMed ID: 26004053
[TBL] [Abstract][Full Text] [Related]
5. Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke.
Baturova MA; Lindgren A; Carlson J; Shubik YV; Olsson SB; Platonov PG
Int J Cardiol; 2015 Nov; 199():248-52. PubMed ID: 26209828
[TBL] [Abstract][Full Text] [Related]
6. Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10years after first-ever ischemic stroke.
Baturova MA; Lindgren A; Carlson J; Shubik YV; Bertil Olsson S; Platonov PG
Int J Cardiol; 2017 Apr; 232():134-139. PubMed ID: 28132778
[TBL] [Abstract][Full Text] [Related]
7. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.
Potpara TS; Polovina MM; Marinkovic JM; Lip GY
Int J Cardiol; 2013 Oct; 168(5):4744-9. PubMed ID: 23958417
[TBL] [Abstract][Full Text] [Related]
8. Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry.
Fudim M; Liu PR; Shrader P; Blanco RG; Allen LA; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Hylek E; Go AS; Thomas L; Peterson ED; Piccini JP
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29654203
[TBL] [Abstract][Full Text] [Related]
9. Treating Specialty and Outcomes in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
Perino AC; Fan J; Schmitt SK; Askari M; Kaiser DW; Deshmukh A; Heidenreich PA; Swan C; Narayan SM; Wang PJ; Turakhia MP
J Am Coll Cardiol; 2017 Jul; 70(1):78-86. PubMed ID: 28662810
[TBL] [Abstract][Full Text] [Related]
10. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
[TBL] [Abstract][Full Text] [Related]
11. Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation.
Guo Y; Wang H; Zhao X; Zhang Y; Zhang D; Ma J; Wang Y; Lip GY
Int J Cardiol; 2013 Oct; 168(5):4678-84. PubMed ID: 23972369
[TBL] [Abstract][Full Text] [Related]
12. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
13. Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).
Fox KAA; Accetta G; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Kayani G; Kakkar AK;
Eur Heart J Qual Care Clin Outcomes; 2018 Jan; 4(1):27-35. PubMed ID: 28950344
[TBL] [Abstract][Full Text] [Related]
14. P-wave duration and the risk of atrial fibrillation: Results from the Copenhagen ECG Study.
Nielsen JB; Kühl JT; Pietersen A; Graff C; Lind B; Struijk JJ; Olesen MS; Sinner MF; Bachmann TN; Haunsø S; Nordestgaard BG; Ellinor PT; Svendsen JH; Kofoed KF; Køber L; Holst AG
Heart Rhythm; 2015 Sep; 12(9):1887-95. PubMed ID: 25916567
[TBL] [Abstract][Full Text] [Related]
15. Mortality and cerebrovascular events after radiofrequency catheter ablation of atrial fibrillation.
Ghanbari H; Başer K; Jongnarangsin K; Chugh A; Nallamothu BK; Gillespie BW; Başer HD; Suwanagool A; Crawford T; Latchamsetty R; Good E; Pelosi F; Bogun F; Morady F; Oral H
Heart Rhythm; 2014 Sep; 11(9):1503-11. PubMed ID: 24813379
[TBL] [Abstract][Full Text] [Related]
16. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE.
Goto S; Merrill P; Wallentin L; Wojdyla DM; Hanna M; Avezum A; Easton JD; Harjola VP; Huber K; Lewis BS; Parkhomenko A; Zhu J; Granger CB; Lopes RD; Alexander JH
Eur Heart J Cardiovasc Pharmacother; 2018 Apr; 4(2):75-81. PubMed ID: 29385429
[TBL] [Abstract][Full Text] [Related]
18. Impact of Awareness and Patterns of Nonhospitalized Atrial Fibrillation on the Risk of Mortality: The Reasons for Geographic And Racial Differences in Stroke (REGARDS) Study.
O'Neal WT; Efird JT; Judd SE; McClure LA; Howard VJ; Howard G; Soliman EZ
Clin Cardiol; 2016 Feb; 39(2):103-10. PubMed ID: 26880475
[TBL] [Abstract][Full Text] [Related]
19. Irregularity and lack of p waves in short tachycardia episodes predict atrial fibrillation and ischemic stroke.
Johnson LSB; Persson AP; Wollmer P; Juul-Möller S; Juhlin T; Engström G
Heart Rhythm; 2018 Jun; 15(6):805-811. PubMed ID: 29448015
[TBL] [Abstract][Full Text] [Related]
20. Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort study.
Fauchier L; Clementy N; Bisson A; Stamboul K; Ivanes F; Angoulvant D; Babuty D; Lip GY
Clin Res Cardiol; 2017 Mar; 106(3):202-210. PubMed ID: 27695988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
